We found that CXorf56 transcription levels are significantly upregulated in breast cancer tissues, suggesting that CXorf56 plays a key role in the development of breast cancer and can be utilized as a specific therapeutic target for breast cancer. This evidence concerns the gene STEEP1 and breast carcinoma.